Claims for Patent: 7,741,373

✉ Email this page to a colleague

Summary for Patent: 7,741,373

Title:	Methods of use of fenofibric acid
Abstract:	Fenofibric acid formulations comprising 105 mg of fenofibric acid are described as well as methods of use thereof. Dosage forms include, for example, immediate-release dosage forms.
Inventor(s):	Arnold; Kristin Anne (Morrisville, PA), Feng; Hengsheng (Cherry Hill, NJ)
Assignee:	Mutual Pharmacuetical Company, Inc. (Philadelphia, PA)
Application Number:	12/501,678
Patent Claims:	1. A method of treating a patient in need of treatment for hypertriglyceridemia, comprising administering to the patient an immediate-release 105 mg fenofibric acid dosage form without regard to meals, wherein immediate-release is release of 90% or greater of the fenofibric acid in the dosage form at 2 hours measured in a single pH buffer.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.